Global Transplantation Clinical Trials Industry 2016 Market Outlook 2021

June 2016 | 101 pages | ID: GC75FE082A6EN
QYResearch

Abstracts

This report studies the global Transplantation Clinical Trials market, focusing on the market development, technology, market competition, status and outlook, the data statistics includes the revenue, cost and margin by regions, by end users, by key players, from 2011 to 2016, and forecast from 2016 to 2021.

This report focuses on

Market segment by product type, covering

• Type 1
• Type 2
• Type 3

Market segment by regions, covering

• USA
• EU
• China
• Japan

Market segment by players, covering

• Novartis AG
• Astellas Pharma Inc
• Pfizer Inc
• Sanofi
• Bristol-Myers Squibb Company
• Amgen Inc
• Alexion Pharmaceuticals, Inc
• Parexel International Corporation

Contents

Global Transplantation Clinical Trials Market Outlook 2021

1 INDUSTRY OVERVIEW

1.1 Market Overview
  1.1.1 Market Status (definition and market size)
  1.1.2 Market Outlook (market potential)
1.2 Market Analysis by Type
1.3 Market Analysis by End Users
1.4 Competitive Analysis
  1.4.1 Development Trends
  1.4.2 New Entrants
  1.4.3 Exterior Environment Opportunities
  1.4.4 Exterior Environment Threatens

2 INDUSTRY CHAIN AND COST ANALYSIS

2.1 Industry Chain Analysis
2.2 Cost Analysis
  2.2.1 Administrative/Communication Cost
  2.2.2 Labor Cost
  2.2.3 Cost of Rent and Utilities

3 GLOBAL MARKET SIZE 2011-2016E

3.1 Global Revenue of Transplantation Clinical Trials
3.2 Global Revenue of Transplantation Clinical Trials by Regions
3.3 Global Revenue of Transplantation Clinical Trials by End Users
3.4 Global Revenue of Transplantation Clinical Trials by Key Players
3.5 Global Revenue of Transplantation Clinical Trials by Types

4 MARKET ANALYSIS BY REGIONS 2011-2016E

4.1 USA Market Analysis
  4.1.1 USA Market Status and Outlook
  4.1.2 USA Revenue and Growth of Transplantation Clinical Trials
  4.1.3 USA Revenue and Growth of Transplantation Clinical Trials by End Users
  4.1.4 USA Revenue of Transplantation Clinical Trials by Key Players
  4.1.5 USA Revenue of Transplantation Clinical Trials by Key Types
4.2 EU Market Analysis
  4.2.1 EU Market Status and Outlook
  4.2.2 EU Revenue and Growth of Transplantation Clinical Trials
  4.2.3 EU Revenue and Growth of Transplantation Clinical Trials by End Users
  4.2.4 EU Revenue of Transplantation Clinical Trials by Key Players
  4.2.5 EU Revenue of Transplantation Clinical Trials by Key Types
4.3 China Market Analysis
  4.3.1 China Market Status and Outlook
  4.3.2 China Revenue and Growth of Transplantation Clinical Trials
  4.3.3 China Revenue and Growth of Transplantation Clinical Trials by End Users
  4.3.4 China Revenue of Transplantation Clinical Trials by Key Players
  4.3.5 China Revenue of Transplantation Clinical Trials by Key Types
4.3 China Market Analysis
  4.3.1 China Market Status and Outlook
  4.3.2 China Revenue and Growth of Transplantation Clinical Trials
  4.3.3 China Revenue and Growth of Transplantation Clinical Trials by End Users
  4.3.4 China Revenue of Transplantation Clinical Trials by Key Players
  4.3.5 China Revenue of Transplantation Clinical Trials by Key Types
4.4 Japan Market Analysis
  4.4.1 Japan Market Status and Outlook
  4.4.2 Japan Revenue and Growth of Transplantation Clinical Trials
  4.4.3 Japan Revenue and Growth of Transplantation Clinical Trials by End Users
  4.4.4 Japan Revenue of Transplantation Clinical Trials by Key Players
  4.4.5 Japan Revenue of Transplantation Clinical Trials by Key Types

5 MARKET ANALYSIS BY TYPE 2011-2016E

5.1 Type 1 Market Analysis
  5.1.1 Type 1 Development Status and Outlook
  5.1.2 Market Size of Transplantation Clinical Trials in Type
5.2 Type 2 Market Analysis
  5.2.1 Type 2 Development Status and Outlook
  5.2.2 Market Size of Transplantation Clinical Trials in Type
5.3 Type 3 Market Analysis
  5.3.1 Type 3 Development Status and Outlook
  5.3.2 Market Size of Transplantation Clinical Trials in Type

6 MARKET ANALYSIS BY END USERS 2011-2016E

7 MARKET COMPETITION ANALYSIS BY PLAYERS 2011-2016E

7.1 Novartis AG
  7.1.1 Company Profile
  7.1.2 Product Type
  7.1.3 Transplantation Clinical Trials Business Analysis
  7.1.4 Market Position and Market Area
  7.1.5 Contact Information
7.2 Astellas Pharma Inc
  7.2.1 Company Profile
  7.2.2 Product Type
  7.2.3 Transplantation Clinical Trials Business Analysis
  7.2.4 Market Position and Market Area
  7.2.5 Contact Information
7.3 Pfizer Inc
  7.3.1 Company Profile
  7.3.2 Product Type
  7.3.3 Transplantation Clinical Trials Business Analysis
  7.3.4 Market Position and Market Area
  7.3.5 Contact Information
7.4 Sanofi
  7.4.1 Company Profile
  7.4.2 Product Type
  7.4.3 Transplantation Clinical Trials Business Analysis
  7.4.4 Market Position and Market Area
  7.4.5 Contact Information
7.5 Bristol-Myers Squibb Company
  7.5.1 Company Profile
  7.5.2 Product Type
  7.5.3 Transplantation Clinical Trials Business Analysis
  7.5.4 Market Position and Market Area
  7.5.5 Contact Information
7.6 Amgen Inc
  7.6.1 Company Profile
  7.6.2 Product Type
  7.6.3 Transplantation Clinical Trials Business Analysis
  7.6.4 Market Position and Market Area
  7.6.5 Contact Information
7.7 Alexion Pharmaceuticals, Inc
  7.7.1 Company Profile
  7.7.2 Product Type
  7.7.3 Transplantation Clinical Trials Business Analysis
  7.7.4 Market Position and Market Area
  7.7.5 Contact Information
7.8 Parexel International Corporation
  7.8.1 Company Profile
  7.8.2 Product Type
  7.8.3 Transplantation Clinical Trials Business Analysis
  7.8.4 Market Position and Market Area
  7.8.5 Contact Information

8 POTENTIAL CUSTOMERS AND MARKETS

8.1 Emerging Countries
  8.1.1 China Development Potential
  8.1.2 India Development Potential
  8.1.3 Southeast Asia (Indonesia, Thailand, Vietnam etc.)
8.2 Mature Regions Development Potential
  8.2.1 North America Development Potential
  8.2.2 EU Development Potential
  8.2.3 Japan Development Potential
8.3 Potential Customers

9 MARKET FORECAST 2016-2021E

9.1 Global Market Size Forecast
9.2 Market Forecast by Regions
  9.2.1 USA Market Forecast
  9.2.2 EU Market Forecast
  9.2.3 China Market Forecast
  9.2.4 Japan Market Forecast
9.3 Market Forecast by Type
9.4 Market Forecast by End Users

10 CONCLUSION